July 1, 2008Open Access

EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

EML4-ALK is found in the minority of NSCLC. ALK kinase inhibitors alone or in combination may nevertheless be clinically effective treatments for NSCLC patients whose tumors contain EML4-ALK.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Jussi Koivunen

Craig H. Mermel

Kreshnik Zejnullahu

Journals

Clinical Cancer Research

Actions

Institutions

Harvard University

Massachusetts Institute of Technology

Brigham and Women's Hospital

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study